Loading clinical trials...
Loading clinical trials...
Exploration of Immunologic Mechanisms of Immune Interference and/or Cross-Neutralizing Immunity Following Various Administration Schedules With CYD Tetravalent Dengue Vaccine
Conditions
Interventions
CYD Dengue Vaccine
CYD Dengue Vaccine
+2 more
Locations
1
United States
Syracuse, New York, United States
Start Date
November 5, 2013
Primary Completion Date
November 25, 2015
Completion Date
November 25, 2015
Last Updated
March 24, 2022
NCT06579755
NCT04486638
NCT07007585
NCT06665035
NCT07040202
NCT06388785
Lead Sponsor
Sanofi Pasteur, a Sanofi Company
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions